Monographie - Metoprolol tartrate - Stabilis 4.0

Dernière mise à jour :
17/12/2025

Antiarythmique

Metoprolol tartrate

Solution buvable

injectable

Stabilité des préparations

Stabilité en mélange

Facteur influençant la stabilité

Compatibilités

Bibliographie

pdf

Structure chimique

Solution buvable

Bibliographie

Solution buvable

Bibliographie : Metoprolol tartrate

	Type	Source
653	Revue	Das Gupta V. Quantification of metoprolol tartrate and propranolol hydrochloride in pharmaceutical dosage forms : stability of metoprolol in aqueous mixture. Int J Pharm Compound 1997 ; 1: 125-127.
2435	Revue	Allen LV, Jr, Erickson MA, Stability of labetalol hydrochloride, metoprolol tartrate, verapamil hydrochloride, and spironolactone with hydrochlorothiazide in extemporaneously compounded oral liquids Am J Health-Syst Pharm 1996 ; 53: 2304-2309.
2556	Revue	Peterson GM, Meaney MF, Reid CA. Stability of extemporaneously prepared mixtures of metoprolol and spironolactone. Aust J Hosp Pharm 1989 ; 19,: 344-346.
2931	Revue	Yamreudeewong W, Dolence EK, Pahl D. Stability of two extemporaneously prepared oral metoprolol and carvedilol liquids. Hosp Pharm 2006 ; 41: 254-259.
3994	Revue	De Oliveira Ferreira A, Polonini H C, Loures da Silva S, Cerqueira de Melo V Augusto, de Andrade L, Fernandes Brand?o Marcos A. Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions. Int J Pharm Compound 2017 ; 3: 255-263
5084	Revue	Davis C, Ip K, Banov D, Zdoryk O. Stability Study of Pediatric Oral Suspensions Formulated with PCCA SuspendIt Vehicle Used for the Treatment of Cardiovascular Disease. Int J Pharm Compound 2025 ; 29, 4: 279-290.

Mentions Légales